Overview

The CANabidiol Use for RElief of Short Term Insomnia

Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the effect of 50 mg and 100 mg per day oral CBD product versus a placebo over 8 weeks on insomnia severity in adults aged 18-65 years old with insomnia symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Bod Australia
Collaborator:
Woolcock Institute of Medical Research
Treatments:
Cannabidiol